Author(s)

Mohamed Serag¹, Mohamed Mahmoud^1*, Ahmed Seleem², Mervat Elnagar¹

¹Radiation Oncology department, National Cancer Institute, Cairo University, Giza, Egypt.
²Clinical Oncology Department, Faculty of Medicine, Cairo University, Giza, Egypt.

Aim of the study: To identify all clinico-pathological data, different treatment modalities and the different prognostic factors which affected the locoregional control (LC), disease-free survival (DFS), and overall survival (OS) of Type II endometrial cancer patients. Patients and methods: Data of Type II endometrial carcinoma patients who presented to the Radiation Oncology department, National Cancer Institute, Cairo University during the period from (2000-2012) were retrospectively reviewed. Results: Multivariate analysis identified stage as an independent prognostic factor for OS & DFS, and age was an independent prognostic factor for DFS and LC. Low pretreatment hemoglobin levels significantly affected OS. Conclusion: Large and multicentric clinical trials are required to further study this group of patients and define optimum treatment modalities.

Endometrial Carcinoma, Radiotherapy, Chemotherapy

Serag, M. , Mahmoud, M. , Seleem, A. and Elnagar, M. (2016) A Retrospective Study of the Treatment Results & Patterns of Failure of Type II Endometrial Cancer Patients Treated at Radiotherapy Department, NCI, Cairo University during the Period from January 2000 till December 2012. Journal of Cancer Therapy, 7, 600-608. doi: 10.4236/jct.2016.78063.